Dr. David Scanlon is a Lecturer in Biology & Biopharmaceutical Science in the Department of Science, SETU.
He completed his PhD in Biochemistry with Professor Paul Engel in University College Dublin in 2007. Prior to that he received his Bachelor’s degree in Biochemistry (Hons) from UCD (2003) and a National Certificate in Applied Biology (Hons) from WIT (2000). After being awarded his PhD, Dr. Scanlon worked in the Development department of Wyeth Biotech (later Pfizer), specialising in downstream processing.
Subsequently he spent 7 years as a Post-Doctoral Fellow and Research Associate with Dr. Mike Salter at The Hospital for Sick Children in Toronto (aka SickKids). During his tenure at SickKids he ran multiple projects to identify biotherapeutic targets for chronic pain in the CNS, with a particular focus on characterising protein-protein interactions of NMDA and P2X7 receptors.
He is the Y2 Course leader for the Programme in Molecular Biology with Biopharmaceutical Science in Waterford. He currently teaches undergraduate modules on subjects including enzymology, genetics, microbial biotechnology, physiology and pharmacology, and his research centres on identifying protein interactomes associated with epilepsy.
SETU modules (Lectures/Practicals)
Semester 1
Research Methodology and Literature Review (4th yr)
